Terveystalo

7.78 EUR

-1.02%

12,201 following
Corporate customer

TTALO

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Terveystalo

20192020202120222023202420252026e2027e2028e2029e
Revenue1,030.7986.41,154.61,259.11,286.51,340.01,278.81,211.21,230.51,266.51,303.5
growth-%-4.3 %17.1 %9.0 %2.2 %4.2 %-4.6 %-5.3 %1.6 %2.9 %2.9 %
EBITDA170.1158.0198.1168.9179.1222.5237.5214.7241.7252.8263.8
EBIT (adj.)86.571.7114.473.493.1140.5156.3132.7145.9154.8161.1
EBIT81.467.2110.133.9-14.7116.1137.5114.6135.9144.8151.1
Profit before taxes67.056.7100.431.0-38.989.7116.294.4114.2124.1131.2
Net income53.945.980.024.5-42.271.792.775.392.5100.5106.2
EPS (adj.)0.420.390.650.440.440.720.850.710.790.860.90
growth-%-7.8 %68.6 %-32.2 %0.6 %62.2 %18.1 %-16.7 %11.9 %8.0 %5.3 %
Dividend0.130.260.280.280.300.480.640.500.600.660.67
Dividend ratio30.9 %72.5 %44.8 %145.1 %-90.2 %84.7 %87.5 %84.1 %82.1 %83.1 %80.0 %

Profitability and return on capital

20192020202120222023202420252026e2027e2028e2029e
EBITDA-%16.5 %16.0 %17.2 %13.4 %13.9 %16.6 %18.6 %17.7 %19.6 %20.0 %20.2 %
EBIT-% (adj.)8.4 %7.3 %9.9 %5.8 %7.2 %10.5 %12.2 %11.0 %11.9 %12.2 %12.4 %
EBIT-%7.9 %6.8 %9.5 %2.7 %-1.1 %8.7 %10.8 %9.5 %11.0 %11.4 %11.6 %
ROE8.2 %13.6 %4.1 %-7.6 %13.5 %16.4 %13.0 %15.6 %16.2 %16.5 %
ROI5.9 %9.6 %2.9 %-1.3 %10.2 %12.1 %9.8 %11.5 %12.3 %12.8 %